Cross Border IP Assignment Defects in Venture Formation
Cross-border IP assignment defects stem from incompatible statutory regimes, broken execution mechanics, and deferred tax liabilities during formation.
March in Rights
Meaning
Regulatory authority permits a government agency to mandate the licensing of a federally funded invention to a third party when the original patent holder fails to achieve practical application or meet public health requirements. These march in rights act as a conditional override on exclusive patent control. Federal funding agreements contain this provision to prevent technology hoarding by private entities.
The power exists strictly to ensure inventions reach the marketplace when the initial developer neglects or abandons the commercialization path.
Exercise Trigger
Administrative assessment of non-use occurs when a patent holder neglects to prepare a product for commercial distribution. Agency officials evaluate the efforts made by the company to bring the technology to market during a specific evaluation period. Failure to demonstrate credible progress toward manufacturing or public availability alerts the funding body to the potential for intervention.
Evidence of neglect warrants a formal hearing to determine whether the public interest demands a transfer of usage permissions to another organization.
License Requirement
Mandated licensing forces the current patent owner to grant access to another party under reasonable terms. Financial arrangements usually follow industry standards to provide fair compensation to the original inventor. Dispute resolution mechanisms address disagreements over the definition of reasonable royalties during the transition period.
Contractual obligations remain in effect for the new licensee, including adherence to the original research objectives and production quality targets.
Commercial Impact
Investment risk increases when patent holders operate under the shadow of potential license seizure. Venture capital participants monitor the application status of government-funded research to gauge the likelihood of agency intervention. Market certainty diminishes because the threat of compulsory licensing changes the valuation of intellectual property portfolios.
Regulatory oversight prevents the capture of public innovation by firms that prioritize patent blocking over product development.